右氯苯那敏,dextrochlorpheniramine
1)dextrochlorpheniramine右氯苯那敏
1.Objective To develop LC-MS/MS method for the simultaneous determination of paracetamol and dextrochlorpheniramine in human plasma and to study the urinary excretions of the drugs.目的建立高效液相色谱-串联质谱联用法同时测定人尿中对乙酰氨基酚和右氯苯那敏(解热镇痛药)浓度及其排泄。
英文短句/例句

1.Simultaneous Determination of Paracetamol and Dextrochlorpheniramine in Human Plasma by LC-MS/MSLC-MS/MS同时测定人血浆中对乙酰氨基酚和右氯苯那敏浓度
2.Chlorphenamine Maleate马来酸氯苯那敏(扑尔敏)
3.Literature Analysis of ADRs Caused by Chlorphenamine氯苯那敏致不良反应45例文献分析
4.Determination of Chlorphenamine Maleatein in Xiaoyan Zhimin Pills by HPLCHPLC法测定消炎止敏丸中马来酸氯苯那敏的含量
5.Determination of uniformity of chlorpheniramine maleate in compound diclofenac sodium chlorphenamine maleate tablets by HPLCHPLC法测定氯芬黄敏片中马来酸氯苯那敏含量均匀度
6.Triprolidine vs chlorphenamine male_ ate in treating urticaria曲普利啶与马来酸氯苯那敏治疗荨麻疹的比较
7.Bacterial Endotoxins Test of Chlorphenamine Maleate Injection马来酸氯苯那敏注射液的细菌内毒素检查
8.Quantitative Determination of CPA by HPLCHPLC法测定马来酸氯苯那敏中间体CPA的含量
9.Determination of Chlorphenamine Maleate in Mangguo Zhike Tablets by HPLC对芒果止咳片中马来酸氯苯那敏的含量测定
10.Preparation and Clinical Observation of Compound Chlorphenamine Maleate Tincture复方马来酸氯苯那敏酊的制备及疗效观察
11.Determination of Chlorphenamine Maleate in Keteling Capsule by HPLCHPLC法测定咳特灵胶囊中马来酸氯苯那敏的含量
12.Simultaneous Determination of Cloperastine,Chlorpheniramine and Psedoephedrine Concentrations in Human Plasma by LC-MSLC-MS同时测定人血浆中氯哌丁、氯苯那敏和伪麻黄碱
13.An allergic response was diagnosed and she received IV chlorphenamine and dexamethasone.她被诊断为过敏反应,并给予氯苯那敏和地塞米松静脉注射。
14.RP-lP-HPLC Determination of Naphazoline Hydrochloride and Chlorphenamine Maleate in Naphazoline Hydrochloride,Chlorphenamine Maleate and Vitamin B_(12) Eye DropsHPLC测定萘敏维滴眼液中盐酸萘甲唑林和马来酸氯苯那敏的含量
15.HPLC determination of content uniformity of chlorphenamine maleate in Paracetamol, Aminophenazone,Caffeine and Chlorphenamine Maleate Tablets高效液相色谱法测定酚氨咖敏片中马来酸氯苯那敏含量均匀度
16.AIM: To study pharmacokinetics and bioavailability of chlorpheniramine maleate tablets in young healthy volunteers.目的研究马来酸氯苯那敏片剂在健康人体内的相对生物利用度。
17.Study on the Content Uniformity of Chlorphenamine Maleate in Wei C Yinqiao Granules维C银翘颗粒中马来酸氯苯那敏含量均匀度测定的研究
18.Determination of the Content of Chlorphenamine Maleate in Kangle Biyan Tablets by HPLC高效液相法测定康乐鼻炎片的马来酸氯苯那敏含量
相关短句/例句

R-Chlorpheniramine右旋氯苯那敏
3)dextrochlorpheniramine maleate马来酸右氯苯那敏
4)chlorpheniramine[,kl?:feni'r?min]氯苯那敏
1.Simultaneous determination of ephedrine and chlorpheniramine in human plasma by a highly sensitive liquid chromatography-tandem mass spectrometric method;高灵敏度LC/MS/MS法同时测定人血浆中麻黄碱和氯苯那敏
2.Simultaneous determination of chlorpheniramine and caffeine concentrations in human plasma by liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry液相色谱-大气压化学电离-串联质谱法同时测定人血浆中氯苯那敏和咖啡因的含量
3.Electrochemical characterization of chlorpheniramine and its interaction with β-Cyclodextrins in Na 2HPO 4 buffer solutions with different pH values were studied with linear sweep voltammetry.以氯苯那敏和 β$C环糊精为研究对象 ,利用电化学方法测定了它们相互作用形成超分子化合物的结合常数。
5)chlorphenamine氯苯那敏
1.Determination of phenylephrine and chlorphenamine in nasal drops by HPLC;HPLC法同时测定去氧肾上腺素、氯苯那敏的含量
2.In order to investigate the effect of dexamethasone,cyclosporin and chlorphenamine on basophils in vitro,we assessed activation marker on the surface of basophils stimulated by anti-IgE antibody.目的在体外建立IgE介导的嗜碱粒细胞活化模型,通过加入不同药物浓度的地塞米松、环孢素和氯苯那敏,观察嗜碱粒细胞表面活化标记表达的变化,探讨药物对体外嗜碱粒细胞活化的作用。
3.Objective To analyze the clinical features,correlation factors,prevention and cure of adverse drug reactions(ADR) caused by chlorphenamine.目的探讨氯苯那敏致药品不良反应(ADR)的一般规律和特点。
6)dexbrompheniramine右溴苯那敏
延伸阅读

氯苯那敏分子式:C16H19ClN2分子量:274.80CAS号:132-22-9性质:油状液体。沸点142℃(133Pa)。制备方法:由2-对氯苄基吡啶经两步缩合而得。在干燥的反应锅内,加入氨钠、无水甲苯,加热至回流,将2-对氯苄基吡啶和溴代乙醛缩二乙醇同时滴入。加毕,回流反应8h。冷却静置,取甲苯液,固体物用少量水溶解后以甲苯提取。将提取液与甲苯液合并,水洗至中性,回收甲苯,得3-对氯苯-3-(2-吡啶基)-丙醛缩二乙醇。将其与DMF混匀加入反应锅,搅拌下加入甲酸与水的混合液。加热至110-120℃反应2h,150-160℃反应3h。冷却,减压回收DMF,加热水稀释,用碱液调至pH14。然后用甲苯提取,用水洗提取液至中性,回收甲苯后减压蒸馏,收集150-190℃馏分,得氯屈米通。用途:抗组织胺药。与氯屈米通相类似,溴苯吡胺也中抗组织胺药。溴苯吡胺的生产方法也与氯屈米通相类似,只不过将起始原料用溴苯化合物代替。